• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Product Type
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global biologics CDMO market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global biologics CDMO market 2017 – 2021 ($ billion)
o 4.2 Type Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Type Segment 2017 – 2021 ($ billion)
o 4.3 Product type Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Product type Segment 2017 – 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type – Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Mammalian – Market size and forecast 2022-2027
o Exhibit 34: Chart on Mammalian – Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Mammalian – Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Mammalian – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Mammalian – Year-over-year growth 2022-2027 (%)
o 6.4 Microbial – Market size and forecast 2022-2027
o Exhibit 38: Chart on Microbial – Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Microbial – Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Microbial – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Microbial – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ billion)
• 7 Market Segmentation by Product Type
o 7.1 Market segments
o Exhibit 43: Chart on Product Type – Market share 2022-2027 (%)
o Exhibit 44: Data Table on Product Type – Market share 2022-2027 (%)
o 7.2 Comparison by Product Type
o Exhibit 45: Chart on Comparison by Product Type
o Exhibit 46: Data Table on Comparison by Product Type
o 7.3 Biologics – Market size and forecast 2022-2027
o Exhibit 47: Chart on Biologics – Market size and forecast 2022-2027 ($ billion)
o Exhibit 48: Data Table on Biologics – Market size and forecast 2022-2027 ($ billion)
o Exhibit 49: Chart on Biologics – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Biologics – Year-over-year growth 2022-2027 (%)
o 7.4 Biosimilars – Market size and forecast 2022-2027
o Exhibit 51: Chart on Biosimilars – Market size and forecast 2022-2027 ($ billion)
o Exhibit 52: Data Table on Biosimilars – Market size and forecast 2022-2027 ($ billion)
o Exhibit 53: Chart on Biosimilars – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Biosimilars – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Product Type
o Exhibit 55: Market opportunity by Product Type ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 57: Chart on Market share by geography 2022-2027 (%)
o Exhibit 58: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 59: Chart on Geographic comparison
o Exhibit 60: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 61: Chart on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 62: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 63: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 64: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 65: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 66: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 67: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 69: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 70: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 71: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 73: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 74: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 75: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 77: Chart on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 78: Data Table on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 79: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 China – Market size and forecast 2022-2027
o Exhibit 81: Chart on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 82: Data Table on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 83: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 85: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 86: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 87: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 France – Market size and forecast 2022-2027
o Exhibit 89: Chart on France – Market size and forecast 2022-2027 ($ billion)
o Exhibit 90: Data Table on France – Market size and forecast 2022-2027 ($ billion)
o Exhibit 91: Chart on France – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on France – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 93: Chart on Japan – Market size and forecast 2022-2027 ($ billion)
o Exhibit 94: Data Table on Japan – Market size and forecast 2022-2027 ($ billion)
o Exhibit 95: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 97: Market opportunity by geography ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 98: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 100: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 101: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 102: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 103: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 104: AbbVie Inc. – Overview
o Exhibit 105: AbbVie Inc. – Product / Service
o Exhibit 106: AbbVie Inc. – Key news
o Exhibit 107: AbbVie Inc. – Key offerings
o 12.4 Binex Co. Ltd.
o Exhibit 108: Binex Co. Ltd. – Overview
o Exhibit 109: Binex Co. Ltd. – Product / Service
o Exhibit 110: Binex Co. Ltd. – Key offerings
o 12.5 Boehringer Ingelheim International GmbH
o Exhibit 111: Boehringer Ingelheim International GmbH – Overview
o Exhibit 112: Boehringer Ingelheim International GmbH – Business segments
o Exhibit 113: Boehringer Ingelheim International GmbH – Key news
o Exhibit 114: Boehringer Ingelheim International GmbH – Key offerings
o Exhibit 115: Boehringer Ingelheim International GmbH – Segment focus
o 12.6 Bora Pharmaceuticals Co. Ltd.
o Exhibit 116: Bora Pharmaceuticals Co. Ltd. – Overview
o Exhibit 117: Bora Pharmaceuticals Co. Ltd. – Product / Service
o Exhibit 118: Bora Pharmaceuticals Co. Ltd. – Key offerings
o 12.7 Catalent Inc.
o Exhibit 119: Catalent Inc. – Overview
o Exhibit 120: Catalent Inc. – Business segments
o Exhibit 121: Catalent Inc. – Key news
o Exhibit 122: Catalent Inc. – Key offerings
o Exhibit 123: Catalent Inc. – Segment focus
o 12.8 Evonik Industries AG
o Exhibit 124: Evonik Industries AG – Overview
o Exhibit 125: Evonik Industries AG – Business segments
o Exhibit 126: Evonik Industries AG – Key news
o Exhibit 127: Evonik Industries AG – Key offerings
o Exhibit 128: Evonik Industries AG – Segment focus
o 12.9 FUJIFILM Holdings Corp
o Exhibit 129: FUJIFILM Holdings Corp – Overview
o Exhibit 130: FUJIFILM Holdings Corp – Business segments
o Exhibit 131: FUJIFILM Holdings Corp – Key offerings
o Exhibit 132: FUJIFILM Holdings Corp – Segment focus
o 12.10 Grifols SA
o Exhibit 133: Grifols SA – Overview
o Exhibit 134: Grifols SA – Business segments
o Exhibit 135: Grifols SA – Key offerings
o Exhibit 136: Grifols SA – Segment focus
o 12.11 JRS PHARMA GmbH and Co. KG
o Exhibit 137: JRS PHARMA GmbH and Co. KG – Overview
o Exhibit 138: JRS PHARMA GmbH and Co. KG – Product / Service
o Exhibit 139: JRS PHARMA GmbH and Co. KG – Key offerings
o 12.12 Lonza Group Ltd.
o Exhibit 140: Lonza Group Ltd. – Overview
o Exhibit 141: Lonza Group Ltd. – Business segments
o Exhibit 142: Lonza Group Ltd. – Key news
o Exhibit 143: Lonza Group Ltd. – Key offerings
o Exhibit 144: Lonza Group Ltd. – Segment focus
o 12.13 Novartis AG
o Exhibit 145: Novartis AG – Overview
o Exhibit 146: Novartis AG – Business segments
o Exhibit 147: Novartis AG – Key offerings
o Exhibit 148: Novartis AG – Segment focus
o 12.14 Rentschler Biopharma SE
o Exhibit 149: Rentschler Biopharma SE – Overview
o Exhibit 150: Rentschler Biopharma SE – Product / Service
o Exhibit 151: Rentschler Biopharma SE – Key offerings
o 12.15 Samsung Biologics Co. Ltd.
o Exhibit 152: Samsung Biologics Co. Ltd. – Overview
o Exhibit 153: Samsung Biologics Co. Ltd. – Product / Service
o Exhibit 154: Samsung Biologics Co. Ltd. – Key offerings
o 12.16 Toyobo Co. Ltd.
o Exhibit 155: Toyobo Co. Ltd. – Overview
o Exhibit 156: Toyobo Co. Ltd. – Business segments
o Exhibit 157: Toyobo Co. Ltd. – Key offerings
o Exhibit 158: Toyobo Co. Ltd. – Segment focus
o 12.17 WuXi Biologics Cayman Inc.
o Exhibit 159: WuXi Biologics Cayman Inc. – Overview
o Exhibit 160: WuXi Biologics Cayman Inc. – Product / Service
o Exhibit 161: WuXi Biologics Cayman Inc. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 162: Inclusions checklist
o Exhibit 163: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 164: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 165: Research methodology
o Exhibit 166: Validation techniques employed for market sizing
o Exhibit 167: Information sources
o 13.5 List of abbreviations
o Exhibit 168: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Market Segmentation by Product Type
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global biologics CDMO market 2017 – 2021 ($ billion)
Exhibits19: Historic Market Size – Type Segment 2017 – 2021 ($ billion)
Exhibits20: Historic Market Size – Product type Segment 2017 – 2021 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Type – Market share 2022-2027 (%)
Exhibits31: Data Table on Type – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Mammalian – Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Mammalian – Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Mammalian – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Mammalian – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Microbial – Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Microbial – Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Microbial – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Microbial – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ billion)
Exhibits43: Chart on Product Type – Market share 2022-2027 (%)
Exhibits44: Data Table on Product Type – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Product Type
Exhibits46: Data Table on Comparison by Product Type
Exhibits47: Chart on Biologics – Market size and forecast 2022-2027 ($ billion)
Exhibits48: Data Table on Biologics – Market size and forecast 2022-2027 ($ billion)
Exhibits49: Chart on Biologics – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Biologics – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Biosimilars – Market size and forecast 2022-2027 ($ billion)
Exhibits52: Data Table on Biosimilars – Market size and forecast 2022-2027 ($ billion)
Exhibits53: Chart on Biosimilars – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Biosimilars – Year-over-year growth 2022-2027 (%)
Exhibits55: Market opportunity by Product Type ($ billion)
Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits57: Chart on Market share by geography 2022-2027 (%)
Exhibits58: Data Table on Market share by geography 2022-2027 (%)
Exhibits59: Chart on Geographic comparison
Exhibits60: Data Table on Geographic comparison
Exhibits61: Chart on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits62: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits63: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits64: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits65: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits66: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits67: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits70: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits71: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits74: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits75: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on US – Market size and forecast 2022-2027 ($ billion)
Exhibits78: Data Table on US – Market size and forecast 2022-2027 ($ billion)
Exhibits79: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on China – Market size and forecast 2022-2027 ($ billion)
Exhibits82: Data Table on China – Market size and forecast 2022-2027 ($ billion)
Exhibits83: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits86: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits87: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on France – Market size and forecast 2022-2027 ($ billion)
Exhibits90: Data Table on France – Market size and forecast 2022-2027 ($ billion)
Exhibits91: Chart on France – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on France – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Japan – Market size and forecast 2022-2027 ($ billion)
Exhibits94: Data Table on Japan – Market size and forecast 2022-2027 ($ billion)
Exhibits95: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits97: Market opportunity by geography ($ billion)
Exhibits98: Impact of drivers and challenges in 2022 and 2027
Exhibits99: Overview on Criticality of inputs and Factors of differentiation
Exhibits100: Overview on factors of disruption
Exhibits101: Impact of key risks on business
Exhibits102: Vendors covered
Exhibits103: Matrix on vendor position and classification
Exhibits104: AbbVie Inc. – Overview
Exhibits105: AbbVie Inc. – Product / Service
Exhibits106: AbbVie Inc. – Key news
Exhibits107: AbbVie Inc. – Key offerings
Exhibits108: Binex Co. Ltd. – Overview
Exhibits109: Binex Co. Ltd. – Product / Service
Exhibits110: Binex Co. Ltd. – Key offerings
Exhibits111: Boehringer Ingelheim International GmbH – Overview
Exhibits112: Boehringer Ingelheim International GmbH – Business segments
Exhibits113: Boehringer Ingelheim International GmbH – Key news
Exhibits114: Boehringer Ingelheim International GmbH – Key offerings
Exhibits115: Boehringer Ingelheim International GmbH – Segment focus
Exhibits116: Bora Pharmaceuticals Co. Ltd. – Overview
Exhibits117: Bora Pharmaceuticals Co. Ltd. – Product / Service
Exhibits118: Bora Pharmaceuticals Co. Ltd. – Key offerings
Exhibits119: Catalent Inc. – Overview
Exhibits120: Catalent Inc. – Business segments
Exhibits121: Catalent Inc. – Key news
Exhibits122: Catalent Inc. – Key offerings
Exhibits123: Catalent Inc. – Segment focus
Exhibits124: Evonik Industries AG – Overview
Exhibits125: Evonik Industries AG – Business segments
Exhibits126: Evonik Industries AG – Key news
Exhibits127: Evonik Industries AG – Key offerings
Exhibits128: Evonik Industries AG – Segment focus
Exhibits129: FUJIFILM Holdings Corp – Overview
Exhibits130: FUJIFILM Holdings Corp – Business segments
Exhibits131: FUJIFILM Holdings Corp – Key offerings
Exhibits132: FUJIFILM Holdings Corp – Segment focus
Exhibits133: Grifols SA – Overview
Exhibits134: Grifols SA – Business segments
Exhibits135: Grifols SA – Key offerings
Exhibits136: Grifols SA – Segment focus
Exhibits137: JRS PHARMA GmbH and Co. KG – Overview
Exhibits138: JRS PHARMA GmbH and Co. KG – Product / Service
Exhibits139: JRS PHARMA GmbH and Co. KG – Key offerings
Exhibits140: Lonza Group Ltd. – Overview
Exhibits141: Lonza Group Ltd. – Business segments
Exhibits142: Lonza Group Ltd. – Key news
Exhibits143: Lonza Group Ltd. – Key offerings
Exhibits144: Lonza Group Ltd. – Segment focus
Exhibits145: Novartis AG – Overview
Exhibits146: Novartis AG – Business segments
Exhibits147: Novartis AG – Key offerings
Exhibits148: Novartis AG – Segment focus
Exhibits149: Rentschler Biopharma SE – Overview
Exhibits150: Rentschler Biopharma SE – Product / Service
Exhibits151: Rentschler Biopharma SE – Key offerings
Exhibits152: Samsung Biologics Co. Ltd. – Overview
Exhibits153: Samsung Biologics Co. Ltd. – Product / Service
Exhibits154: Samsung Biologics Co. Ltd. – Key offerings
Exhibits155: Toyobo Co. Ltd. – Overview
Exhibits156: Toyobo Co. Ltd. – Business segments
Exhibits157: Toyobo Co. Ltd. – Key offerings
Exhibits158: Toyobo Co. Ltd. – Segment focus
Exhibits159: WuXi Biologics Cayman Inc. – Overview
Exhibits160: WuXi Biologics Cayman Inc. – Product / Service
Exhibits161: WuXi Biologics Cayman Inc. – Key offerings
Exhibits162: Inclusions checklist
Exhibits163: Exclusions checklist
Exhibits164: Currency conversion rates for US$
Exhibits165: Research methodology
Exhibits166: Validation techniques employed for market sizing
Exhibits167: Information sources
Exhibits168: List of abbreviations